LABORATORY NEWS
-
Augurex Secures Health Canada Approval For SPINEstat, A First-in-Class Diagnostic Blood Test For Axial Spondyloarthritis
Augurex Life Sciences Corp., a leader in autoimmune biomarker-based diagnostics, today announced that Health Canada has approved SPINEstat, a first-in-class diagnostic blood test for axial spondyloarthritis (axSpA), as a Class II medical device.
- Automated Removal Of Microplate Seals
- Nanospeed Diagnostics Receives Health Canada Approval For Test4D Test
- HealthTrackRx Partners With CDC To Launch Rapid PCR Test For H5N1 To Support Early Detection Amid Nationwide Outbreaks
- NEC Laboratories Europe And Data-Driven.AI Enhance AI Medical Diagnosis To Improve The Early Detection Of Disease And Illness
ARCHIVED NEWSLETTER
- 04.08.25 -- 9 Reasons Why You Should Consider AI In Analytical Instrument Qualification
- 03.25.25 -- Comparison Of Sterilization Methods: Vaporized Vs. Aerosolized Hydrogen Peroxide
- 03.11.25 -- ASTM International Pharmaceutical Cleaning Standards: Current Status And Future Direction
- 02.25.25 -- 2024 Trends In FDA Observations For Sterile Drug Manufacturers
- 02.11.25 -- How Laboratory Manuals Fail Sites And Sponsors
This website uses cookies to ensure you get the best experience on our website. Learn more